A common pathway for diabetic eye screening: update Archived

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

Info

This video has been archived as it is more than 2 years old. CPD is no longer available.

x Mobile version: slides + audio only
-15s 00:00 / 12:32 +15s
Minimise video

Lynne Lacey provides an update on the pathway for screening for diabetic eye disease. She discusses what has changed — such as new surveillance practices and grading definitions — and how different parts of healthcare fit in to the pathway.

This lecture was part of an event called ‘National diabetic eye screening conference 2014: integration — where do I fit in?’ at The Royal Society of Medicine in London. 

Date of lecture: 30th April 2014

This video is available for iPad via Safari

Length: 00:12:32

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

53:49

Professor Nick Wareham, MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge

CPD Archived View
21:02

Dr Lisa Webber, Consultant Gynaecologist and Specialist in Reproductive Medicine, St Mary's Hospital.

CPD Archived View
27:37

Professor Julie Lovegrove, Deputy Director, Institute for Cardiovascular and Metabolic Research, University of Reading. 

CPD Archived View
29:11

Dr Nicola Bridges, Consultant Paediatric Endocrinologist, Chelsea & Westminster Hospital. 

CPD Archived View
13:43

Dr Breanne Everett, CEO and President, Orpyx, Calgary, Canada.

Free Archived View
29:37

Gordon Rustin, Director of Medical Oncology, East & North Hertfordshire NHS Trust. 

CPD Archived View
19:29

Robert Sherriff, National Operations Director, NHS Screening Programmes, Public Health England. 

Archived View
12:32

Lynne Lacey, Programme, Manager, NHS Diabetic Eye Screening Programme. 

Archived View
12:54

Madeline Johnson, Consultant in Public Health, Regional Quality Assurance Lead North, UK.

Archived View